CTRI/2020/10/028680尚未招募3 期
Colchicine as a Therapeutic Drug in the Management of Oral Submucous Fibrosis - A Randomized Clinical Trail
SVM Mounika0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with clinically diagnosed oral sub mucous fibrosis.
- •2. Patients who are ready to accept regular follow up protocol.
- •3. Patients willing to participate in the study
排除标准
- •1. patients with stage - III OSMF
- •2. Patients already receiving other treatment for OSMF
- •3. Pregnant Patients
- •4. Patient receiving immunosuppressant drugs
- •5. Patients with difficulty in mouth opening due to reasons other than OSMFas in pericoronitis, TMJ disorders
- •6. Patients having fibrotic lesions other than OSMF
研究者
相似试验
招募中
2 期
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0IRCT20160920029889N4Mazandaran University of Medical Sciences10
招募中
3 期
Evaluation of colchicine in treatment of coronavirusPulmonary infection of COVD19.Coronavirus infection, unspecifiedB34.2IRCT20200418047126N1Ardabil University of Medical Sciences100
招募中
2 期
Colchicine effects on treatment of COVID-19COVID-19 pneumonia.COVID-19, virus identifiedU07.1IRCT20190804044429N5Mazandaran University of Medical Sciences110
已完成
2 期
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70
进行中（未招募）
1 期
Treatment with COLchicine of patients affected by coronavirus disease (COVID-19): a Pilot StudyStudy population: patients with COVID-19 pneumonia with oxygen saturation deficiency and requiring hospitalization assistance.MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001475-33-ITDIPARTIMENTO DI MEDICINA, UNIVERSITà DI PERUGIA308